Inventiva SA
F:6IV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inventiva SA
F:6IV
|
FR |
|
F
|
Franklin Resources Inc
BMV:BEN
|
US |
|
F
|
Fresenius SE & Co KGaA
OTC:FSNUY
|
DE |
|
D
|
Diamondback Energy Inc
F:7DB
|
US |
|
S
|
Sierra Bancorp
NASDAQ:BSRR
|
US |
|
CP Axtra PCL
SET:CPAXT
|
TH |
|
HCA Healthcare Inc
NYSE:HCA
|
US |
|
Sonic Automotive Inc
NYSE:SAH
|
US |
|
ILPRA SpA
MIL:ILP
|
IT |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
C
|
Credit Suisse Group AG
XHAM:CSX
|
CH |
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
US |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
T
|
Triumph New Energy Co Ltd
OTC:LUOYF
|
CN |
|
Imperial Brands PLC
LSE:IMB
|
UK |
|
C
|
Chayo Group PCL
SET:CHAYO
|
TH |
|
Simon Property Group Inc
NYSE:SPG
|
US |
|
Gaming and Leisure Properties Inc
NASDAQ:GLPI
|
US |
|
BP PLC
LSE:BP
|
UK |
Bankruptcy Probability
Inventiva SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Inventiva SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Inventiva SA
PAR:IVA
|
929.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Inventiva SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Inventiva SA has total debt of 27.6m EUR. This includes both short-term (0 EUR) and long-term (27.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.
